Colorectal Cancer, Childhood

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, Hypermutated Brain Tumors, Ependymoma or Medulloblastoma
Status:
Recruiting
Last Changed:
Jan 17, 2019
First Changed:
Feb 10, 2015
Disease(s):
Constitutional Mismatch Repair Deficiency Syndrome
Intervention(s):
Diffusion Tensor ImagingDiffusion Weighted ImagingDynamic Contrast-Enhanced Magnetic Resonance ImagingDynamic Susceptibility Contrast-Enhanced Magnetic Resonance ImagingLaboratory Biomarker AnalysisMagnetic Resonance Spectroscopic ImagingPembrolizumabPerfusion Magnetic Resonance Imaging
Positron Emission Tomography/Magnetic Resonance Imaging in Patients
Status:
Terminated
Last Changed:
Aug 14, 2015
First Changed:
Mar 20, 2012
Disease(s):
Colon Cancer
Intervention(s):
magnetic resonance imaging with positron emission tomography scanning

Connect. Empower. Inspire.